Edition:
India

Shilpa Medicare Ltd (SHME.NS)

SHME.NS on National Stock Exchange of India

294.05INR
13 Dec 2019
Change (% chg)

Rs-1.80 (-0.61%)
Prev Close
Rs295.85
Open
Rs295.85
Day's High
Rs299.00
Day's Low
Rs292.10
Volume
6,127
Avg. Vol
20,685
52-wk High
Rs435.05
52-wk Low
Rs208.10

Latest Key Developments (Source: Significant Developments)

Shilpa Medicare Says Successful Closure Of Inspection, With Receipt Of EIR From FDA
Wednesday, 4 Dec 2019 

Dec 4 (Reuters) - Shilpa Medicare Ltd ::SHILPA MEDICARE -SUCCESSFUL CLOSURE OF INSPECTION, WITH RECEIPT OF EIR FROM FDA FOR INSPECTION AT SITE LOCATED AT RAICHUR, KARNATAKA.  Full Article

India's Shilpa Medicare Sept Quarter Consol Net Profit Rises
Monday, 11 Nov 2019 

Nov 11 (Reuters) - Shilpa Medicare Ltd ::SEPT QUARTER CONSOL NET PROFIT 507.8 MILLION RUPEES VERSUS 422.7 MILLION RUPEES YEAR AGO.SEPT QUARTER CONSOL REVENUE FROM OPERATIONS 2.90 BILLION RUPEES VERSUS 1.62 BILLION RUPEES YEAR AGO.  Full Article

Shilpa Medicare Gets USFDA Final Nod For Erlotinib Tablets
Wednesday, 6 Nov 2019 

Nov 6 (Reuters) - Shilpa Medicare Ltd ::GETS USFDA FINAL NOD FOR ITS ANDA, ERLOTINIB TABLETS, 25 MG, 100 MG, AND 150 MG.  Full Article

India's Shilpa Medicare Sets Final Dividend Of 1 Rupee Per Share
Monday, 23 Sep 2019 

Sept 23 (Reuters) - Shilpa Medicare Ltd ::SAYS SETS FINAL DIVIDEND OF 1 RUPEE PER SHARE.  Full Article

India's Shilpa Medicare June-Qtr Consol Net Profit Drops
Tuesday, 13 Aug 2019 

Aug 13 (Reuters) - Shilpa Medicare Ltd ::JUNE QUARTER CONSOL NET PROFIT 157.4 MILLION RUPEES VERSUS 336.4 MILLION RUPEES YEAR AGO.JUNE QUARTER REVENUE FROM OPERATIONS 1.61 BILLION RUPEES VERSUS 1.98 BILLION RUPEES YEAR AGO.  Full Article

Shilpa Medicare Gets USFDA Final Approval For Its ANDA, Docetaxel Injection
Friday, 17 May 2019 

May 17 (Reuters) - Shilpa Medicare Ltd ::SAYS RECEIVED U.S FOOD AND DRUG ADMINISTRATION FINAL APPROVAL FOR ITS ANDA, DOCETAXEL INJECTION.  Full Article

Shilpa Medicare Gets U.S. FDA Final Nod For ANDA, Zoledronic Acid Injection
Thursday, 16 May 2019 

May 16 (Reuters) - Shilpa Medicare Ltd ::RECEIVED U.S. FOOD AND DRUG ADMINISTRATION FINAL APPROVAL FOR ITS ANDA, ZOLEDRONIC ACID INJECTION, 4 MG/5 ML.  Full Article

Shilpa Medicare Gets U.S. FDA Tentative Nod For ANDA, Bortezomid For Injection, 3.5Mg/Vial
Tuesday, 9 Apr 2019 

April 9 (Reuters) - Shilpa Medicare Ltd ::GETS U.S. FDA TENTATIVE APPROVAL FOR ITS ANDA, BORTEZOMID FOR INJECTION, 3.5MG/VIAL.  Full Article

India's Shilpa Medicare Sept-Qtr Consol Net Profit Rises
Wednesday, 14 Nov 2018 

Nov 14 (Reuters) - Shilpa Medicare Ltd ::SEPT QUARTER CONSOL NET PROFIT 422.7 MILLION RUPEES VERSUS PROFIT 341.5 MILLION RUPEES YEAR AGO.SEPT QUARTER CONSOL REVENUE FROM OPERATIONS 1.62 BILLION RUPEES VERSUS 2.04 BILLION RUPEES YEAR AGO.  Full Article

India's Shilpa Medicare March Quarter Consol Profit Falls
Monday, 28 May 2018 

May 28 (Reuters) - Shilpa Medicare Ltd ::MARCH QUARTER CONSOL PROFIT 306.4 MILLION RUPEES VERSUS PROFIT 373.3 MILLION RUPEES YEAR AGO.MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 2.34 BILLION RUPEES VERSUS 2.26 BILLION RUPEES YEAR AGO.  Full Article